We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lipomics Technologies Sign Research Collaboration Agreement for Pharmacometabolic Markers

News   May 22, 2007

 
Lipomics Technologies Sign Research Collaboration Agreement for Pharmacometabolic Markers
 
 
Advertisement
 

RELATED ARTICLES

Scientists Develop the First Known Methyl Transferase Ribozyme

News

The research group of chemistry professor Claudia Höbartner is now reporting a scientific breakthrough: Her team at Julius-Maximilians-Universität Würzburg (JMU) in Bavaria, Germany, has developed a ribozyme that can attach a very specific small chemical change at a very specific location in a target RNA.

READ MORE

Biomarkers Could Be Used in Quick COVID-19 Blood Screening Strategy

News

A new study suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites. Three metabolites identified in the study could act as biomarkers and hold potential to be measured through an inexpensive blood test to quickly screen patients for the disease.

READ MORE

Spanish Study Explores Vitamin D Deficiency in COVID-19 Patients

News

Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE